GE HealthCare to Deploy 300+ Advanced CT Scanners Across Indonesia Under Landmark SIHREN Program

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicab...

December 18, 2025 | Thursday | News
Minghui Pharma Secures FDA IND Clearance to Launch Global Phase 3 Trials of MHB018A in Thyroid Eye Disease

Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announc...

December 16, 2025 | Tuesday | News
Vanda Targets Mid-2026 Approval With Imsidolimab BLA for Generalized Pustular Psoriasis

Vanda Pharmaceuticals Inc.  announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ims...

December 16, 2025 | Tuesday | News
InnoCare’s Orelabrutinib Meets Primary Endpoint in Phase IIb SLE Study, Advances to Phase III

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced th...

December 15, 2025 | Monday | News
China Approves InnoCare’s Breakthrough TRK Inhibitor Zurletrectinib for Adult and Adolescent Solid Tumors

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced that its next-generation TRK inhibitor, zurletrectinib (ICP-72...

December 12, 2025 | Friday | News
Eurofins Expands Consumer Product Testing Footprint with Major New Facility in Vietnam

Eurofins Consumer Product Testing Vietnam has completed a major expansion, seeing the laboratory move to a purpose-built 7,000 sq. m laboratory in Ho Chi...

December 11, 2025 | Thursday | News
Resmed Receives FDA Clearance for Smart Comfort, the First AI-Enabled Tool for Personalized CPAP Therapy Settings

Resmed , the leading health technology company focused on sleep, breathing and care delivered in the home, announced it has received U.S. Food and Drug A...

December 09, 2025 | Tuesday | News
GlycoNex Enters CDMO Agreement to Advance First-in-Class Anti-HMGB1 Antibody Into Clinical Trials in Japan

Collaboration with Science Tokyo spinout underscores GlycoNex's integrated antibody development and manufacturing capabilities in support of first-in-cla...

December 09, 2025 | Tuesday | News
Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Tumor Profiling Program to China

Pillar Biosciences and AstraZeneca announced an expansion of their existing laboratory access program for NGS-based kitted liquid biopsy tumor profi...

December 09, 2025 | Tuesday | News
Viatris Secures $815 Million in Strategic Exit From Biocon Biologics Stake

Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Co...

December 08, 2025 | Monday | News
Zai Lab Medicines Renewed in China’s 2025 National Reimbursement Drug List

Zai Lab Limited  announced that the following medicines and indications have been renewed in the 2025 National Reimbursement Drug List (NRDL) releas...

December 08, 2025 | Monday | News
Daniella Cramp Emphasizes Asia’s Growing Role in Global Biopharma as Thermo Fisher Expands Network in Korea Singapore and India

    “Asia continues to play an increasingly important role in advancing innovation across the global biopharma industry,” said Dani...

December 04, 2025 | Thursday | News
Imugene and JW Therapeutics Collaborate on Innovative CF33-CD19 and CAR-T Therapy for Solid Tumors

Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlyt...

December 01, 2025 | Monday | News
Angel Yeast Expands Specialty Yeast Capabilities with Automated Production and Pilot Platform

Angel Yeast (SH600298), a global leader in yeast and fermentation solutions, has begun trial production at its new specialty yeast project in the Baiyang...

December 01, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close